Arrowhead Publishers is pleased to announce its Annual Translational Microbiome Conferenceis coming back to Boston on April 18-20, 2018. The conference will once again bring together the top companies in the microbiome space working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products.

The meeting will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products.

With a broad focus spanning multiple disease states (oncology, dermatology, inflammatory disorders, among others) attendees will have the opportunity to hear the leading companies discuss the work they have underway and how they are meeting these challenges head on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.

Conference topics will include speakers and panels on:

♦ Animal Models

♦ Bioinformatics Challenges

♦ Intellectual Property Management

♦ Investment Deals and Approaches

♦ Pharma Deals in the Microbiome Space

♦  The Need for Standards

This year brings several exciting additions to the conference designed to offer attendees real education, insights and benefits that they can implement in their own organizations.

Focused Parallel Tracks

This year’s conference will again feature a parallel consumer track, as well as nutrition and skin tracks, on the second day closely focused on the issues in those specific industries and the challenges common to those companies trying to enter the microbiome space in those areas.

Pre-Conference Workshops

Interactive, hands-on, intensive pre-conference workshops hosted by microbiome service providers working real time with the leading microbiome companies to help attendees understand real-world issues and understand how these issues impact their business plans while providing tools and best practice tips to start implementing solutions in their own organizations.